Plasma exosomes induced by remote ischaemic preconditioning attenuate myocardial ischaemia/reperfusion injury by transferring MIR-24 article

Cell Death and Disease

Volumn 9, Issue 3, 2018, Pages

  Minghua, Wen ^a   Zhijian, Gong ^a   Chahua, Huang ^a   Qiang, Liang ^b   Minxuan, Xu ^a   Luqiao, Wang ^a   Weifang, Zhang ^a   Peng, Lu ^a   Biming, Zhan ^a   Lingling, Yu ^a   Zhenzhen, Wang ^a   Jianqing, Xu ^a   Huihui, Bao ^a   Xiaozhong, Wang ^a   Xiaoshu, Cheng ^a  

^a NANCHANG UNIVERSITY   (China)

^b Jiangxi Province Key Laboratory of Molecular Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; BIM PROTEIN; CD63 ANTIGEN; CD81 ANTIGEN; CD9 ANTIGEN; HYDROGEN PEROXIDE; MICRORNA; MICRORNA 132; MICRORNA 144; MICRORNA 150; MICRORNA 195; MICRORNA 210; MICRORNA 214; MICRORNA 24; MICRORNA 34A; UNCLASSIFIED DRUG; MIRN24 MICRORNA, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARDIAC MUSCLE CELL; CONTROLLED STUDY; DOWN REGULATION; EXOSOME; H9C2(2-1) CELL LINE; HEART FUNCTION; HEART INFARCTION SIZE; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIC PRECONDITIONING; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NONHUMAN; OXIDATIVE STRESS; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REMOTE ISCHAEMIC PRECONDITIONING; ANIMAL; BIOLOGICAL MODEL; BLOOD; DISEASE MODEL; GENETICS; HEART INFARCTION PREVENTION; MALE; METABOLISM; MOUSE; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; EXOSOMES; HYDROGEN PEROXIDE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MICE; MICRORNAS; MODELS, BIOLOGICAL; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; RATS, SPRAGUE-DAWLEY;

EID: 85042554769     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/s41419-018-0274-x     Document Type: Article

References (42)

1. Hausenloy, D. J. et al. Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart. Cardiovasc. Res. 6, 113 (2017).
2. Giricz, Z. et al. Cardioprotection by remote ischemic preconditioning of the heart is mediated by extracellular vesicles. J. Mol. Cell. Cardiol. 68, 75-78 (2014).
3. Vicencio, J. M. et al. Plasma exosomes protect the myocardium from ischemia reperfusion injury. J. Am. Coll. Cardiol. 65, 1525-1536 (2015).
4. Tkach, M. & Théry, C. Communication by extracellular vesicles: where we are and where we need to go. Cell 164, 1226-1232 (2016).
5. Creemers, E. E., Tijsen, A. J. & Pinto, Y. M. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ. Res. 110, 483-495 (2012).
6. Skog, J. et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470-1476 (2008).
7. De Rosa, S., Curcio, A. & Indolfi, C. Emerging role of microRNAs in cardiovascular diseases. Circ. J. 78, 567-575 (2014).
8. Li, Z. & Rana, T. M. Therapeutic targeting of microRNAs: current status and future challenges. Nat. Rev. Drug Discov. 13, 622-638 (2014).
9. Iaconetti, C., Sorrentino, S., De Rosa, S. & Indolfi, C. Exosomal miRNAs in heart disease. Physiology 31, 16-24 (2016).
10. Ong, S. G. et al. Cross talk of combined gene and cell therapy in ischemic heart disease role of exosomal microRNA transfer. Circulation 130, S60-S69 (2014).
11. Wang, Y. et al. Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium. Int. J. Cardiol. 192, 61-69 (2015).
12. Braicu, C. et al. Exosomes as divine messengers: are they the Hermes of modern molecular oncology? Cell Death Differ. 22, 34-45 (2015).
13. Malik, Z. A. et al. Cardiac myocyte exosomes: stability, HSP60, and proteomics. Am. J. Physiol. Heart Circ. Physiol. 304, H954-H965 (2013).
14. Li, X. et al. MicroRNA-150 aggravates H2O2-induced cardiac myocyte injury by down-regulating c-myb gene. Acta Biochim. Biophys. Sin. (Shanghai) 45, 734-741 (2013).
15. Lin, Y. et al. Involvement of microRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells. J. Biol. Chem. 284, 7903-7913 (2009).
16. Li, J. et al. MicroRNA-144 is a circulating effector of remote ischemic preconditioning. Basic Res. Cardiol. 109, 423 (2014).
17. Aurora, A. B. et al. MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca2+overload and cell death. J. Clin. Invest. 122, 1222-1232 (2012).
18. Bernardo, B. C. et al. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc. Natl Acad. Sci. USA 109, 17615-17620 (2012).
19. Boon, R. A. & Dimmeler, S. MicroRNAs in myocardial infarction. Nat. Rev. Cardiol. 12, 135-142 (2015).
20. Hullinger, T. G. et al. Inhibition of miR-15 protects against cardiac ischemic injury. Circ. Res. 110, 71-81 (2012).
21. Li, J. et al. Mitofusin 1 is negatively regulated by microRNA140 in cardiomyocyte apoptosis. Mol. Cell. Biol. 34, 1788-1799 (2014).
22. Yamaguchi, T. et al. Repeated remote ischemic conditioning attenuates left ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure after myocardial infarction. Int. J. Cardiol. 15, 239-246 (2015).
23. Cosme, J., Liu, P. P. & Gramolini, A. O. The cardiovascular exosome: current perspectives and potential. Proteomics 13, 1654-1659 (2013).
24. Matsuda, T. et al. NF2 activates Hippo signaling and promotes ischemia/ reperfusion injury in the heart. Circ. Res. 119, 596 (2016).
25. Li, N. et al. Opposite effects of HDAC5 and p300 on MRTF-A-related neuronal apoptosis during ischemia/reperfusion injury in rats. Cell Death Dis. 8, e2624 (2017).
26. Fulda, S., Gorman, A. M., Hori, O. & Samali, A. Cellular stress responses: cell survival and cell death. Int. J. Cell Biol. 2010, 214074 (2010).
27. Sanada, S., Komuro, I. & Kitakaze, M. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. Am. J. Physiol. Heart Circ. Physiol. 301, H1723-H1741 (2011).
28. Wang, X. et al. Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1. Cardiovasc. Res. 94, 379-390 (2012).
29. Wang, X. et al. Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells. J. Mol. Cell. Cardiol. 74, 139-150 (2014).
30. Gupta, S. & Knowlton, A. A. HSP60 trafficking in adult cardiacmyocytes: role of the exosomal pathway. Am. J. Physiol. Heart Circ. Physiol. 292, H3052-H3056 (2007).
31. Wang, X. et al. Hsp20-mediated activation of exosome biogenesis in cardiomyocytes improves cardiac function and angiogenesis in diabetic mice. Diabetes 65, 3111-3128 (2016).
32. Qian, L. et al. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J. Exp. Med. 208, 3549-3560 (2011).
33. Gallo, A., Tandon, M., Alevizos, I. & Iiiei, G. G. The majority of microRNAs detecf in serum and saliva is concentrated in exosomes. PLoS ONE 7, e30679 (2012).
34. Kharbanda, R. K. et al. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation 103, 1624-1630 (2001).
35. Konstantinov, I. E. et al. The remote ischemic preconditioning stimulus modifies gene expression in mouse myocardium. J. Thorac. Cardiovasc. Surg. 130, 1326-1332 (2005).
36. Yang, Y. et al. Exosomal transfer of miR-30a between cardiomyocytes regulates autophagy after hypoxia. J. Mol. Med. 94, 711-724 (2016).
37. Ye, W. et al. Plasma-derived exosomes contribute to inflammation via the TLR9-NF-κB pathway in chronic heart failure patients. Mol. Immunol. 87, 114 (2017).
38. Xiao, J. et al. Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4. Cell Death Dis. 7, e2277 (2016).
39. Tang, Y. L., Qian, K., Zhang, Y. C., Shen, L. & Phillips, M. I. Hypoxia-regulated heme oxygenase-1 gene vector in the heart limits cardiac injury after ischemia-reperfusion in vivo. J. Cardiovasc. Pharmacol. Ther. 10, 251-263 (2005).
40. Yamazaki, T. et al. Novel device that produces carbon dioxide mist for myocardial infarction treatment in rats. Circ. J. 76, 1203-1212 (2012).
41. Yamazaki, T. et al. Tolvaptan improves left ventricular dysfunction after myocardial infarction in rats. Circ. Heart Fail. 5, 794-802 (2012).
42. Guo, C., Deng, Y., Liu, J. & Qian, L. Cardiomyocyte-specific role of miR-24 in promoting cell survival. J. Cell. Mol. Med. 19, 103-112 (2015).